Su Min Yoon

Title: Su Min Yoon: Innovator in Target-Specific Non-Antibody Proteins

Introduction

Su Min Yoon is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of target-specific non-antibody proteins. His innovative work has the potential to impact cancer therapeutics significantly.

Latest Patents

Su Min Yoon holds a patent for a "Target-specific non-antibody protein and method for preparing the same." This invention relates to a method for preparing a target-specific non-antibody protein. The process involves selecting non-antibody proteins that have structural complementarity with the target site of a target protein from a non-antibody protein library. It includes calculating the binding energy of the selected non-antibody protein and the target protein, selecting a non-antibody protein with favorable binding energy, and substituting specific amino acid residues to enhance binding affinity. Notably, this invention includes a target-specific non-antibody that binds specifically with the EGFR (Epidermal Growth Factor Receptor) domain 2, which is crucial for cancer treatment.

Career Highlights

Su Min Yoon is affiliated with the Postech Academy-Industry Foundation, where he continues to advance his research and development efforts. His work is characterized by a strong focus on innovative solutions in the field of protein engineering.

Collaborations

Some of his notable coworkers include Yoon Sup Choi and Jun Ho Chung, who contribute to the collaborative efforts in their research projects.

Conclusion

Su Min Yoon's contributions to the field of biotechnology, particularly through his patent on target-specific non-antibody proteins, highlight his role as an innovator in cancer therapeutics. His work exemplifies the potential of targeted treatments in improving patient outcomes.